venBio Select Advisor »

Ptc Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $52M 685k 75.96

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Ptc Therapeutics

Franklin Resources
Tenor Capital Management
OZ Management
D. E. Shaw & Co
Capstone Investment Advisors
Linden Advisors
DeepCurrents Investment Group
Whitebox Advisors
Lazard Asset Management
CSS
SSI Investment Management
BlackRock
venBio Select Advisor
Kornitzer Capital Management
Central Pacific Bank - Trust Division

View all funds holding Ptc Therapeutics